T ype II collagen (CII) is a sequestered molecule found in joint cartilage (1) . Rodents can be induced to generate an autoimmune inflammatory polyarthritis (CIA) by injection of heterologous CII (2) . Susceptibility to arthritis in mice is restricted to the MHC haplotypes H-2q and H-2 r (3). Using recombinant strains, susceptibility in the H-2q haplotype has been narrowed down to the class II molecule encoded by H-2A loci (4) .
Four genes encode the mouse class II molecules; Aa and Ab genes encode for the heavy (H) and light (L) chains of the A molecule respectively whereas Ea and Eb encode for the H and L chains of the E molecule (5) . The A molecule is expressed in all mouse haplotypes studied, whereas the E molecule is not (6) . Four haplotypes of inbred mouse strains, b, s, q, and f, as well as 19 of 33 mouse strains carrying wildtype MHC haplotypes are E negative. Mice of the f and q haplotypes fail to synthesize both Eol and E~ chains. Mice of the b and s haplotypes fail to produce Eo~ chains but do express EB molecules which remain in the cytoplasm as partially glycosilated precursors (7) .
While the critical role of A molecule in the susceptibility to CIA has been stressed (8) , little is known about the role of E molecule in the disease. The human MHC genes (HLA) are also known to play a critical role in the susceptibility to rheumatoid arthritis (RA) (9) . The human class II molecule HLA-DK, which is homologous to mouse H-2E, is clearly important for the predisposition to RA (9) . Previous studies have demonstrated a relationship between severity of RA and increasing DR4 or DR1 frequency (10, 11) . Recent studies have further located the structural element conferring disease susceptibility to the third hypervariable region of the DK~I chain (12) . To determine the role of E molecule in CIA, we analyzed CIA susceptibility in transgenic B10.RQB3-EB a mice which expresses the CIA susceptible Aq genes as well as a viable E molecule. Our results support a protective role of the E/~ d molecule in CIA susceptibility.
Materials and Methods
Mice. All the mice used in this study were bred and maintained in our pathogen-free mouse colony and were 8-12 wk of age at the start of the experiment.
Generation of E~ Transgenic Mice.
A 15.7-kb DNA fragment isolated from a BALB/c cosmid library covering the entire Eb a gene with 4.1 kb of 5'-flanking regulatory region (13) was microinjected into (SWR x B10.M)F, embryos as described (14) . Transgene positive mice were identified by Southern blot analysis. The Eb d gene was introduced into the B10.RQB3 mice by backcrossing. Expression of the EB d molecule was analyzed by flow cytometry as described below (15) . The transgenic mice used in these studies were from the N9-N10 backcross population.
Flow Cytometry. Analysis of EB a and VB TCR expression on PBL were determined by flow cytometry as previously described (15) . Briefly, PBL and were isohted by Ficoll separation, washed, and then incubated with the E~d-specific mAb 34-1-4S (16) for 30 rain at 4~ After washing, the cells were incubated with FITC goat anti-mouse IgG (Accurate Chemicals and Scientific Corp., Westbury, NY) for 30 rain at 4~ washed, and then fixed with 1% paraformaldehyde before analysis. Analysis for V/3 TCR was done using the following mAbs: B20.6, anti-V~2; KT4-10, antiVt54; MRg-4, anti-V~5.1-5.2; 44-22-1. anti-VB6; TR-310, anti-V/~7; F23.2, anti-VBS.2; MR10-2, anti-V139; KT11, anti-V~511; and 14.2, anti-V/~14. Second antibodies consisted of FITC-conjugated mouse anti-rat IgG or IgM or goat anti-mouse IgG. T cell subsets were identified by incubation with mAbs specific for mouse CD4 and CDSa conjugated to R-Phycoerythrin and Red 613, respectively (GIBCO BILL, Gaithersburg, MD). Single-color (for'E/3 a) and three-color (for V/3 TCR) flow cytometric analysis was performed using a FA~ flow cytometer (Becton Dickinson& Co., Mountain View, CA).
Induction and Quantification of Arthritis. Bovine CII (BII), prepared as previously described (3), was dissolved in 0.1 M acetic acid at a concentration of 2 mg/ml then emulsified 1:1 with complete Frennd's adjuvant H37 Ra (Dffco Laboratories, Detroit, MI). Mice received 100/~g of cold emulsion intradermally in the base of the tail. Mice were monitored three times a week from week 3 to 9 post immunization for the onset and development of CIA. The arthritic severity of all four limbs was determined as previously described (3) using a grading system for each paw based on a scale of 0-3 as follows: 0 = normal; 1 = redness and swelling in paws or toes; 2 = deformity in paw; and 3 = ankylosis in the affected joint. The clinical score from each limb was summed thus giving a severity range of 0-12 per mouse. The mean arthritic severity was determined using arthritic animals only.
Measurement of Serura Anti-CIl Antibody. Mice were bled via the taft artery on day 35 post immunization and the level of anti-mouse CII (MII) and anti-BII Abs in serum were determined using a standard ELISA technique (17) . Sera was tested at 1/100 and 1/400 dilutions and compared with a pooled positive control sera. The data is expressed as mean OD _+ SD.
Statistical Analysis. Arthritis incidence between groups was analyzed using chi-square test with Yates' correction. Antibody levels were compared using the Student's t test.
Results
Unlike mice carrying the standard H-2q haplotype (B10.Q, DBA/1), B10.RQB3 recombinant mice synthesize the Eot k molecule. The introduction of a 15.7-kb DNA fragment containing the entire Eb gene from the H-2 d haplotype was sufficient to induce the expression of H-2E molecules in these mice. Flow cytometric analysis showed that the level of surface expression of EB a molecule in the 15.7 transgene positive (E3 d+) mice was comparable to the expression of the same molecule in mice of the H-2 d haplotype ( Fig. 1) . Expression of EBaE~x d in positive control animals (B10.D2) was 54% whereas the expression of EBaEc~ k in 15.7 EB d+ B10.RQB3 mice was 52%. Negligible staining (<1%) was detected in EB a transgene negative (F_d3 d-) littermates and B10 control (H-2 b) mice. Tissue distribution of the Eb transgene was comparable to the endogenous molecule in E positive strains of mice (data not shown).
To investigate the effect of H-2E molecule on the susceptibility to CIA, B10.RQB3 15.7 E3 d § and E3 d-littermates were immunized with bovine CII in CFA. At 9 wk postimmunization, the incidence of arthritis in F43 d* mice was significantly lower than in EB d-littermates (p <0.01, Table  1 ). Among the three E3q5.7 + animals that developed CIA, the extent of arthritis was mild as indicated by arthritic scores from 1 to 2. In contrast, a majority of arthritic E3 a-littermates displayed severe swelling in at least two limbs, and their arthritic scores ranged from 1 to 8.
The inhibitory effect of the 15.7 Eb d transgene was also apparent in the development of antibody against CII. Analysis of sera at a 1/100 dilution showed a 32% reduction in mean OD of BII-reactive Ab mice and a 45% decrease in reactivity against homologous MII Ab in EB d § vs. E3 d-littermates (F <0.001, Table 1 ).
Through flow cytometry, deletion in V~5.1, 5.2, and 11 bearing T cell populations was found in both CD4 and CD8 subsets for E3 d + and EB a-mice (Table 2) . No significant difference in the V3 TCR expression was evident between the two groups with the exception of CD4 +, V~11 + T cells, which were further decreased in E~ d + mice. The deletion of VB5 and VB11 T cells was expected in Eb d transgene negative B10.RQB3 mice since they express an interisotypic AB/E~ molecule known to delete some TCR V3-bearing T cell populations (18) .
To confirm our observations, we used a second line of To examine the suppressive effect of E3 d molecules on arthritis susceptibility in heterozygous mice, the development of CIA in (B10.RQB3 x B10.D2)F1 animals was examined. Flow cytometry showed that the level of surface expression of E/3 a molecule in (B10.KQB3 x B10.D2)F1 mice was similar to B10.RQB3-E/~ a+ and B10.D2 mice (data not shown). The incidence of CIA was compared between (B10.KQB3 x B10.D2)F1 mice and B10.KQB3-E/3 a+ and Eft a-transgenic mice. Like B10.RQB3-E/~ a+ animals, (B10.KQB3 x B10.D2)F1 mice showed a significant reduction in the incidence of arthritis versus B10.KQB3-Efl amice (Table 4) . However, in (B10.RQB3 x B10.D2)F1 mice, the decrease of CIA appeared intermediate compared with B10.KQB3-E/3 a+ animals (40% vs. 25%). This observation shows an inhibitory role of EB a molecule on CIA coded by an endogenous gene as well as a transgene.
Discussion
Here we report for the first time the generation of mice presenting the unique feature of being H-2Aq positive and expressing an H-2E molecule at the same time. As expected, B10.KQB3 mice are CIA susceptible because they express I-Aq (18) . In this strain, E molecules are not expressed since EB q is nonfunctional (7, 8) . By introducing an Eb a transgene, we induced expression of E molecules in B10.KQB3 mice, resulting in a dramatic reduction in the incidence of CIA as well as the level of anti-BII and anti-MII Ab in the serum of EB d + transgenic mice. Analysis of V/3 TCR expression on PBL demonstrated the deletion of V~5.1, V/35.2, and V311 bearing T cells in both Eft a+ and E/$ a-B10.KQB3 mice. Although the presence of the E/3 d molecule justifies these results in E positive mice (20, 21) , it has been demonstrated that the Eot/A3 heterodimer expressed in B10.RQB3 (E/~-) mice plays a similar role to Ec~/Efl dimers in the deletion of several Vfl bearing T cell populations (18) .
Previous studies in other mouse models of autoimmune diseases have demonstrated that the expression of a functional E molecule can play a protective role (22) . By introducing an Ea transgene into nonobese diabetic (NOD) mice, the restored expression of E molecules led to protection against insulin-dependent diabetes meUitus (23) (24) (25) . Also, expression of an Ea d transgene led to a dramatic reduction in the development of autoimmune glomerulonephritis in BXSB mice (26) . There are several distinct differences between our studies and the earlier work in NOD and BXSB mice. First, in the aforementioned studies, expression of E molecules was restored by introduction of a transgene derived for the nonpolymorphic Ea gene. In our studies in CIA, we restored expression of E molecules using a polymorphic Eb gene. Second, Merino et al. (26) reported that resistance to glomerulonephritis in E(x d transgenic BXSB mice was likely due to an exceedingly high copy number (,'o50) of Ea d transgene. Southern blot analysis of our two lines of B10.KQB3-E3 a transgenic mice, 15.7 and 10.2, revealed that the copy number of Eb a transgene was ,'o4-8 and 5-10, respectively. Finally, expression of E molecules in heterozygous H-2 b/d BXSB mice did not protect these animals from the development of autoimmune disease (27) . Likewise, Podolin et al. (28) showed that progeny of an (NOD x NOD.H-2k)~I cross were not protected from the development of diabetes. In our studies, we observed that (B10.KQB3 x B10.D2)F1 mice showed a significant reduction in the incidence of CIA vs. B10.RQB3 animals (Table 4) . Therefore, through both tramgenic and conventional genetic techniques, it appears that introduction of an Eb d gene can alter susceptibility to CIA.
Several nonmutually exclusive mechanisms may account for the protective effect of EB a in CIA. H-2E3 a expression could modulate the T cell repertoire by presenting a "tolerogenic" peptide which leads to the deletion or regulation of arthritogenic T cell clones. It is also possible that a Thl to Th2 switch occurs in the CII response in the context of the E/3 a molecule. It has been shown that the administration of the Th2-derived cytokine IL-4 could facilitate remission of CIA in DBA/1 (H-2q) mice (29) . Finally, it is possible that H-2Aq mediates the presentation of EB peptides derived from the EB a molecule itself which, in turn, modulates the arthritogenic response. Although studies directed towards characterizing naturally processed peptides associated with class II molecules have shown that a portion of peptides bound to H-2A molecules are derived from Ec~ chains (30), the contribution of E3-derived peptides is not clear. Likewise, the scope of self-peptides associated with H-2Aq molecules, which is of interest in our system, remains to be elucidated.
Of importance, B10.KIII (H-2 ~) mice are susceptible to CIA despite expression of functional E molecules (31) . It is possible that, unlike E/3 d, the EB ~ molecule does not lead to protection in CIA. Previously, we found that (B10.Q x B10.K)F1 mice are CIA susceptible, suggesting that E~ k does not play a protective role. Thus, polymorphism of the Eb gene, in the context of particular haplotypes, may play a role in determining self tolerance or autoimmunity. Indeed, preliminary studies suggest that the protective effect of the Eft a molecule in CIA is q haplotype specific; no difference was observed in arthritis susceptibility between transgene positive and negative offspring of a (B10.KQB3-EB d x B10.KIII)Ft cross (our unpublished observations). In B10.RIII mice, H-2E r would be functionally equivalent to DR1 and DR4 subtypes associated in human with KA. Presentation of DRB peptide (E/J peptide) by DQ molecule (H-2A equivalent) may explain observed differences in the role of DR molecules in RA. Variants of the HLA-DR4 family and HLA-DR1 subtypes may be deficient in mediating protection, analogous to H-2E r in r mice.
In closing, our data is the first demonstration of a protective role of E/~ molecules in murine CIA. Experiments are currently underway to further delineate the role of H-2E/3 molecules in CIA and understand the mechanisms involved in the protection. These studies will shed light on the possible role of DR molecules in human RA.
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